| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |